Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W1OX
|
||||
Former ID |
DNC009980
|
||||
Drug Name |
Biphenyl-3-ylcarbamic acid cyclohexyl ester
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530251] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H21NO2
|
||||
Canonical SMILES |
C1CCC(CC1)OC(=O)NC2=CC=CC(=C2)C3=CC=CC=C3
|
||||
InChI |
1S/C19H21NO2/c21-19(22-18-12-5-2-6-13-18)20-17-11-7-10-16(14-17)15-8-3-1-4-9-15/h1,3-4,7-11,14,18H,2,5-6,12-13H2,(H,20,21)
|
||||
InChIKey |
HHVUFQYJOSFTEH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530251] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.